Tel Aviv Medical Center
Tel Aviv Medical Center
Explore linked clinical trials.10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not stated | 2026-09-29 | NCT07351149 | |
| Multi-Component Delirium Prevention Bundle in Older Cardiac Intensive Care Unit Patients | Confusion, Frailty, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, cognitive disorder, delirium, heart disorder, myocardial ischemia, nervous system disorder, psychiatric disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-08-21 | NCT07776184 | |
| Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome | Alzheimer disease, Atrophy, Cognition Disorders, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, anxiety disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, disease, nervous system disorder, neurodegenerative disease, psychiatric disorder, syndromic disease, tauopathy | Recruiting | Not applicable | 2026-07-16 | NCT06821568 | |
| ALS/MND Natural History Study Data Repository | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, X-linked disease, amyotrophic lateral sclerosis, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, progressive bulbar palsy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-05-20 | NCT05966038 | |
| AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-05-12 | NCT07580612 | |
| Telomeres Length in Israeli Fibrotic ILD Patients | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Enrolling by invitation | Not stated | 2026-02-25 | NCT06885515 | |
| PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) | Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, gram-negative bacterial infections | Recruiting | Phase 4 | 2025-08-01 | NCT03671967 | |
| Steps Against the Burden of Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2025-07-17 | NCT07057219 | |
| CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer | cancer, neoplasm | Recruiting | Not stated | 2024-10-24 | NCT06656728 | |
| Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 2 | 2024-05-09 | NCT06407310 |